Could a weight-loss drug ease long COVID fatigue? trial launches.
Symptom relief
Ongoing
This study tests whether tirzepatide (Zepbound), a medicine used for diabetes and weight loss, can reduce Long COVID symptoms like fatigue. About 1000 adults with Long COVID will take either the drug or a placebo for 12 months. All tasks are done from home using surveys and weara…
Phase: PHASE2 • Sponsor: Scripps Translational Science Institute • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC